Comparing the effectiveness of bevacizumab to ranibizumab in patients with exudative agerelated macular degeneration. BRAMD

被引：0
|
作者：
Schauwvlieghe, Ann-Sofie Marie Evelyn [1 ]
Dijkman, Greetje [2 ]
Hooymans, Johanna M. M. [3 ]
Verbraak, Frank D. [1 ,4 ]
Dijkgraaf, Marcel G. [5 ]
Peto, Tunde [6 ,7 ]
Vingerling, Johannes R. [8 ,9 ]
Hoyng, Carel [10 ]
Schlingemann, Reinier O. [1 ,11 ]
机构：
[1] Univ Amsterdam, Acad Med Ctr, Ophthalmol, Amsterdam, Netherlands
[2] Leiden Univ, Med Ctr, Ophthalmol, Leiden, Netherlands
[3] Univ Med Ctr Groningen, Ophthalmol, Groningen, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Biomed Engn & Phys, Amsterdam, Netherlands
[5] Univ Amsterdam, Acad Med Ctr, Clin Res Unit, Amsterdam, Netherlands
[6] Moorfields Eye Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, London, England
[7] UCL Inst Ophthalmol, London, England
[8] Erasmus MC, Ophthalmol, Rotterdam, Netherlands
[9] Erasmus MC, Epidemiol, Rotterdam, Netherlands
[10] Radboud Univ Nijmegen Med Ctr, Ophthalmol, Nijmegen, Netherlands
[11] Netherlands Inst Neurosci, Amsterdam, Netherlands
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2014年 / 55卷 / 13期
关键词：
412 age-related macular degeneration; 466 clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials; 748 vascular endothelial growth factor;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
870
引用
收藏
页数：3
相关论文
共 50 条
  • [31] The effect of ranibizumab versus photodynamic therapy on DNA damage in patients with exudative macular degeneration
    Mozaffarieh, M.
    Schoetzau, A.
    Josifova, T.
    Flammer, Josef
    MOLECULAR VISION, 2009, 15 (125-29): : 1194 - 1199
  • [32] Results at Six Months after Conversion to Aflibercept for Patients on Prior Ranibizumab or Bevacizumab Treatment for Exudative Age-Related Macular Degeneration
    Chan, Clement K.
    Jain, Atul
    Sadda, Srinivas R.
    Varshney, Neeta
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [33] Retinal thickness mapping in exudative age-related macular degeneration.
    Shakoor, A
    Zelkha, R
    Blair, NP
    Gieser, JP
    Shahidi, M
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U934 - U934
  • [34] Systemic bevacizumab (Avastin) therapy for exudative neovascular age-related macular degeneration. The BEAT-AMD-Study
    Schmid-Kubista, K. E.
    Krebs, I.
    Gruenberger, B.
    Zeiler, F.
    Schueller, J.
    Binder, S.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2009, 93 (07) : 914 - 919
  • [35] Comparing the effectiveness and costs of Bevacizumab to Ranibizumab in patients with Diabetic Macular Edema: a randomized clinical trial (the BRDME study)
    Schauwvlieghe, A. M. E.
    Dijkman, G.
    Hooymans, J. M.
    Verbraak, F. D.
    Hoyng, C. B.
    Dijkgraaf, M. G. W.
    Van Leeuwen, R.
    Vingerling, J. R.
    Moll, A. C.
    Schlingemann, Reinier O.
    BMC OPHTHALMOLOGY, 2015, 15
  • [36] Comparing the effectiveness and costs of Bevacizumab to Ranibizumab in patients with Diabetic Macular Edema: a randomized clinical trial (the BRDME study)
    A.M.E. Schauwvlieghe
    G. Dijkman
    J.M. Hooymans
    F.D. Verbraak
    C.B. Hoyng
    M.G.W. Dijkgraaf
    R. Van Leeuwen
    J.R. Vingerling
    A.C. Moll
    Reinier O. Schlingemann
    BMC Ophthalmology, 15
  • [37] Choroidal thickness as a prognostic factor in exudative age related macular degeneration.
    Kumar, Jaya Badhwar
    Ehlers, Justis
    Singh, Rishi P.
    Rachitskaya, Aleksandra V.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [38] COMPARING THE EFFICACY OF BEVACIZUMAB TO RANIBIZUMAB IN PATIENTS WITH DIABETIC MACULAR OEDEMA: THE BRDME STUDY
    Schlingemann, R. O.
    Vader, M. J. C.
    Schauwvlieghe, A. M. E.
    Dijkman, G.
    Hooymans, J. M. M.
    Los, L. I.
    Zwinderman, A. H.
    Peto, T.
    Hoyng, C. B.
    van Leeuwen, R.
    Vingerling, J. R.
    Moll, A. C.
    van Lith-Verhoeven, J. J. C.
    Dijkgraaf, M. G. W.
    Verbraak, F. D.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2019, 29 (03) : NP18 - NP19
  • [39] Comparing the efficacy of bevacizumab to ranibizumab in patients with diabetic macular edema: the BRDME study
    Vader, Maartje J. C.
    Schauwvlieghe, Ann-Sofie M. E.
    Verbraak, Frank D.
    Dijkman, Greetje
    Hooymans, Johanna M. M.
    Los, Leonie I.
    Zwinderman, Aeilko H.
    Peto, Tunde
    Hoyng, Carel B.
    van Leeuwen, Redmer
    Vingerling, Johannes R.
    Moll, Annette C.
    van Lith-Verhoeven, Janneke J. C.
    Dijkgraaf, Marcel G. W.
    Schlingemann, Reinier O.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [40] Comparative Effectiveness of Bevacizumab and Ranibizumab in the Comparison of Age-Related Macular Degeneration Treatments Trials
    Messori, Andrea
    JAMA OPHTHALMOLOGY, 2015, 133 (03) : 363 - 364
12345